For inhibiting the composition and method of ALAS1 gene expressions

• 收藏
• 分享

专利权人:

ALNYLAM PHARMACEUTICALS, INC.;ALNYLAM PHARMACEUTICALS; INC.;ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

发明人:

FITZGERALD, Kevin,DESNICK, Robert, J,QUERBES, William,BETTENCOURT, Brian,YASUDA, Makiko

申请号：

CR20160195

公开号：

CR20160195A

申请日:

2014.10.03

申请国别(地区):

CR

年份:

2016

代理人:

摘要：

The Invention relates to compositions of double stranded ribonucleic acid (dsRNA) addressed to the alas1 Gene and Methods of use of such compositions to alter dsRNA (e.g.Inhibit the expression of alas1).La invención se refiere a composiciones de ácido ribonucleico bicatenario (dsARN) dirigidas al gen ALAS1 y métodos de uso de tales composiciones de dsARN para alterar (por ejemplo, inhibir) la expresión de ALAS1.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/